title: Multiple processes underlie benzodiazepine-mediated increases in the consumption of accepted and avoided stimuli.
abstract: Hyperphagia is a reported side effect of anxiolytic benzodiazepines such as chlordiazepoxide (CDP). Prior research has focused primarily on the ingestive responses to sweet or solid foods. We examined CDP effects on licking for normally accepted and avoided taste solutions across a range of concentrations. The effect of CDP (10 mg/kg) versus saline on the licking patterns of water-restricted rats for water and 3 concentrations of sucrose, saccharin, NaCl, monosodium glutamate (MSG), citric acid, and quinine (Q-HCl) solutions was evaluated during 1 h tests. CDP increased meal size for all tastants except citric acid. Analysis of licking microstructure revealed 3 dissociable effects of CDP. CDP affected oromotor coordination as indicated by a uniform increase in the modal interlick interval for all stimuli. CDP increased meal size as indicated by shorter pauses during consumption of water, MSG, and weaker saccharin concentrations, and by fewer long interlick intervals (250-2000 ms) for normally avoided tastants. CDP also increased meal size by increasing burst size, burst duration, and the initial rate of licking for most solutions, suggesting increased hedonic taste evaluation. CDP did not affect variables associated with postingestive feedback such as meal duration or number of bursts, and the results also suggest that CDP did not enhance the perceived taste intensity. We hypothesize that the reduction of pause duration is consistent with an increased motivation to sample the stimulus that synergizes with changes in taste-mediated responsiveness to some but not all stimuli to yield increases in the consumption of both normally accepted and avoided taste stimuli.
authors.affiliation: Department of Psychology, Wofford College, 429 N. Church Street, Spartanburg, SC 29303, USA. pittmandw@wofford.edu
authors.forename: D W
authors.initials: DW
authors.lastname: Pittman
authors.forename: M R
authors.initials: MR
authors.lastname: McGinnis
authors.forename: L M
authors.initials: LM
authors.lastname: Richardson
authors.forename: E J
authors.initials: EJ
authors.lastname: Miller
authors.forename: M L
authors.initials: ML
authors.lastname: Alimohamed
authors.forename: J P
authors.initials: JP
authors.lastname: Baird
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D002707:Chlordiazepoxide / Q000494:pharmacology*; D019343:Citric Acid / Q000494:pharmacology; D005247:Feeding Behavior / Q000187:drug effects*; D006120:Grooming / Q000187:drug effects*; D006963:Hyperphagia / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D011803:Quinine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012439:Saccharin / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology; D012970:Sodium Glutamate / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology; D013649:Taste / Q000187:drug effects; D014868:Water Deprivation
chemical_list: D014151:Anti-Anxiety Agents; D019343:Citric Acid; D012965:Sodium Chloride; D013395:Sucrose; D002707:Chlordiazepoxide; D011803:Quinine; D012439:Saccharin; D012970:Sodium Glutamate